Search

Your search keyword '"Mitchel Y"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Mitchel Y" Remove constraint Author: "Mitchel Y" Search Limiters Full Text Remove constraint Search Limiters: Full Text
90 results on '"Mitchel Y"'

Search Results

4. Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease

8. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

9. The structural embeddedness of resistance among public managers

11. Narrative Construction as Sensemaking: How a Central Bank Thinks

12. The Creation of Trust Through Interaction and Exchange

15. On Improving Qualitative Methods in Public Administration Research

16. The creation of trust through interaction and exchange: the role of consideration in organizations

18. Bureaucratic Politics: The View from Below

20. The Structural Embeddedness of Resistance among Public Managers

23. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group

26. Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia

28. Book Reviews

38. Morality, Rationality, and Efficiency: New Perspectives on Socio-Economics

39. Coordinating for the Collective Good

40. Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

41. Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia

44. The Moral Dimension: Toward a New Economics

45. Enacting Market Crisis: The Social Construction of a Speculative Bubble

46. Book Review

48. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

49. Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616.

50. Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Catalog

Books, media, physical & digital resources